Licensing deals in the context of cancer research refer to agreements between companies, institutions, or individuals to share the rights to develop, manufacture, and commercialize cancer therapies, diagnostics, or technologies. These deals can involve various structures such as exclusive, non-exclusive, co-exclusive licenses, and more.
